Wnt/β-catenin signaling has been demonstrated to play an important role in bladder cancer progression [15] and studies indicated that DLX6-AS1 regulated bladder cancer progression via Wnt/β-catenin signaling in pancreatic cancer [19]. Here, DLX6 is linked to pancreatic neoplasm.